Modular Medical, Inc.

NasdaqCM MODD

Modular Medical, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD -1.99 M

Modular Medical, Inc. Net Cash Used For Investing Activities is USD -1.99 M for the Trailing 12 Months (TTM) ending September 30, 2024. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Modular Medical, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -112.98 K, a -188.63% change year over year.
Modular Medical, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -39.15 K.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

NasdaqCM: MODD

Modular Medical, Inc.

CEO	Mr. James E. Besser
IPO Date	Feb. 10, 2022
Location	United States
Headquarters	16772 W. Bernardo Drive
Employees	39
Sector	Healthcare
Industries Medical Instruments 3D Printing Automobiles & Vehicles Autonomous Driving Biotechnology Clinical Trials Electric Vehicles (EVs) Robotics Smartphones

Description

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

Key trends

Past 5 years